{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:43:44Z","timestamp":1794372224687,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is caused by inactivating somatic mutations in the\n                    <jats:italic>UBA1<\/jats:italic>\n                    gene. Here, we characterize the immunological landscape of VEXAS syndrome by performing multi-omics single-cell RNA analysis, cytokine multiplex assays, and in vitro functional assays on patients\u2019 peripheral blood. Our data reveals a broad immune system activation with upregulation of multiple inflammatory response pathways and proinflammatory cytokines. Unexpectedly, we find that monocytes have dysfunctional features irrespective of\n                    <jats:italic>UBA1<\/jats:italic>\n                    mutation status, exhibiting impaired efferocytosis and blunted cytokine production in vitro. In contrast,\n                    <jats:italic>UBA1<\/jats:italic>\n                    -mutated NK cells show an upregulation of the inflammation pathways and enhanced cytotoxicity. Within the lymphocyte subsets, predominantly\n                    <jats:italic>UBA1<\/jats:italic>\n                    wild-type, we identify clonal expansion of effector memory CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells and skewed B cell differentiation with loss of transitional B cells and expansion of plasmablasts. Thus, our analysis indicates that VEXAS syndrome is characterized by profound alterations in both adaptive and innate immune systems, accounting for the complex pathophysiology of the disease, and provides a basis to understand the marked clinical heterogeneity and variable disease course.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-59890-0","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:53:22Z","timestamp":1747738402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["In\u00a0depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Hiroki","family":"Mizumaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-0598","authenticated-orcid":false,"given":"Shouguo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-0819","authenticated-orcid":false,"given":"Zhijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Gutierrez-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-3992","authenticated-orcid":false,"given":"Massimiliano","family":"Bissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-5926","authenticated-orcid":false,"given":"Emma M.","family":"Groarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-5334","authenticated-orcid":false,"given":"Haoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemlem","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Quinones","family":"Raffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Darden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Kajigaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6589","authenticated-orcid":false,"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavisha A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"59890_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck, D. B. et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N. Engl. J. Med. 383, 2628\u20132638 (2020).","journal-title":"N. Engl. J. Med"},{"key":"59890_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck, D. B. et al. Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. JAMA 329, 318\u2013324 (2023).","journal-title":"JAMA"},{"key":"59890_CR3","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson, P. C., Patel, B. A. & Young, N. S. VEXAS syndrome. Blood 137, 3591\u20133594 (2021).","journal-title":"Blood"},{"key":"59890_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle, S. et al. Further characterization of clinical and laboratory features in VEXAS syndrome: Large-scale analysis of a multicentre case series of 116 French patients. Br. J. Dermatol 186, 564\u2013574 (2022).","journal-title":"Br. J. Dermatol"},{"key":"59890_CR5","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard-2023-224460","volume":"82","author":"JM Mascaro","year":"2023","unstructured":"Mascaro, J. M. et al. Spanish cohort of VEXAS syndrome: Clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism. Ann. Rheum. Dis. 82, 1594\u20131605 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"59890_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152430","volume":"66","author":"A Vitale","year":"2024","unstructured":"Vitale, A. et al. Orbital\/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry. Semin Arthritis Rheum. 66, 152430 (2024).","journal-title":"Semin Arthritis Rheum."},{"key":"59890_CR7","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah, I. E. et al. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv. 5, 3203\u20133215 (2021).","journal-title":"Blood Adv."},{"key":"59890_CR8","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1182\/blood.2023022329","volume":"143","author":"Y Kusne","year":"2024","unstructured":"Kusne, Y. et al. Venous and arterial thrombosis in patients with VEXAS syndrome. Blood 143, 2190\u20132200 (2024).","journal-title":"Blood"},{"key":"59890_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1182\/blood.2023023723","volume":"144","author":"M Sirenko","year":"2024","unstructured":"Sirenko, M. et al. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes. Blood 144, 1221\u20131229 (2024).","journal-title":"Blood"},{"key":"59890_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101160","volume":"4","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS. Cell Rep. Med 4, 101160 (2023).","journal-title":"Cell Rep. Med"},{"key":"59890_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood-2023-190210","volume":"142","author":"F Gutierrez-Rodrigues","year":"2023","unstructured":"Gutierrez-Rodrigues, F. et al. Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood 142, 244\u2013259 (2023).","journal-title":"Blood"},{"key":"59890_CR12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco, G. et al. RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 26, 1627\u20131640.e1627 (2019).","journal-title":"Cell Rep."},{"key":"59890_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-019-1367-0","volume":"571","author":"AS Nam","year":"2019","unstructured":"Nam, A. S. et al. Somatic mutations and cell identity linked by genotyping of transcriptomes. Nature 571, 355\u2013360 (2019).","journal-title":"Nature"},{"key":"59890_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11591-1","volume":"10","author":"AA Petti","year":"2019","unstructured":"Petti, A. A. et al. A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat. Commun. 10, 3660 (2019).","journal-title":"Nat. Commun."},{"key":"59890_CR15","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong, K. L. et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118, e16\u2013e31 (2011).","journal-title":"Blood"},{"key":"59890_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","volume":"26","author":"M Reyes","year":"2020","unstructured":"Reyes, M. et al. An immune-cell signature of bacterial sepsis. Nat. Med. 26, 333\u2013340 (2020).","journal-title":"Nat. Med"},{"key":"59890_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid, D. et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat. Immunol. 21, 1094\u20131106 (2020).","journal-title":"Nat. Immunol."},{"key":"59890_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41328-0","volume":"14","author":"M Nishide","year":"2023","unstructured":"Nishide, M. et al. Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis. Nat. Commun. 14, 5789 (2023).","journal-title":"Nat. Commun."},{"key":"59890_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204289119","volume":"119","author":"W Zheng","year":"2022","unstructured":"Zheng, W. et al. Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behcet\u2019s disease. Proc. Natl. Acad. Sci. USA 119, e2204289119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59890_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. Jr. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"59890_CR21","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41590-022-01327-7","volume":"23","author":"T Ruckert","year":"2022","unstructured":"Ruckert, T., Lareau, C. A., Mashreghi, M. F., Ludwig, L. S. & Romagnani, C. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. Nat. Immunol. 23, 1551\u20131563 (2022).","journal-title":"Nat. Immunol."},{"key":"59890_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11947-7","volume":"10","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat. Commun. 10, 3931 (2019).","journal-title":"Nat. Commun."},{"key":"59890_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05044-4","volume":"9","author":"S Tasaki","year":"2018","unstructured":"Tasaki, S. et al. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat. Commun. 9, 2755 (2018).","journal-title":"Nat. Commun."},{"key":"59890_CR24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"59890_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.602539","volume":"12","author":"A Stewart","year":"2021","unstructured":"Stewart, A. et al. Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways. Front Immunol. 12, 602539 (2021).","journal-title":"Front Immunol."},{"key":"59890_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44811-4","volume":"15","author":"O Kosmider","year":"2024","unstructured":"Kosmider, O. et al. VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nat. Commun. 15, 910 (2024).","journal-title":"Nat. Commun."},{"key":"59890_CR27","unstructured":"Ganesan, S. et al. Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndrome. bioRxiv, 2024.2005.2019.594376 (2024)."},{"key":"59890_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2012.06.010","volume":"12","author":"CJ Martin","year":"2012","unstructured":"Martin, C. J. et al. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 12, 289\u2013300 (2012).","journal-title":"Cell Host Microbe"},{"key":"59890_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/rheumatology\/keae087","volume":"64","author":"S Riescher","year":"2025","unstructured":"Riescher, S. et al. Susceptibility to mycobacterial infection in VEXAS syndrome. Rheumatol. (Oxf.) 64, 831\u2013835 (2025).","journal-title":"Rheumatol. (Oxf.)"},{"key":"59890_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/ard-2023-224819","volume":"83","author":"B de Valence","year":"2024","unstructured":"de Valence, B. et al. Serious infections in patients with VEXAS syndrome: Data from the French VEXAS registry. Ann. Rheum. Dis. 83, 372\u2013381 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"59890_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae405","volume":"11","author":"M Czech","year":"2024","unstructured":"Czech, M. et al. Opportunistic infections, mortality risk, and prevention strategies in patients with vacuoles, E1 enzyme, x-linked, autoinflammatory, somatic (VEXAS) syndrome. Open Forum Infect. Dis. 11, ofae405 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"59890_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","volume":"457","author":"JC Sun","year":"2009","unstructured":"Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nature 457, 557\u2013561 (2009).","journal-title":"Nature"},{"key":"59890_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/08916934.2012.748751","volume":"46","author":"K Schroeder","year":"2013","unstructured":"Schroeder, K., Herrmann, M. & Winkler, T. H. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 46, 121\u2013127 (2013).","journal-title":"Autoimmunity"},{"key":"59890_CR34","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1172\/JCI78084","volume":"125","author":"J Suurmond","year":"2015","unstructured":"Suurmond, J. & Diamond, B. Autoantibodies in systemic autoimmune diseases: Specificity and pathogenicity. J. Clin. Invest 125, 2194\u20132202 (2015).","journal-title":"J. Clin. Invest"},{"key":"59890_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2013-eular.2766","volume":"72","author":"BF Hoyer","year":"2013","unstructured":"Hoyer, B. F. et al. Role of plasma cell analysis as a biomarker for disease activity in patients with granulomatosis with polyangiitis. Ann. Rheum. Dis. 72, 924\u2013924 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"59890_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/ard.2008.096495","volume":"69","author":"AM Jacobi","year":"2010","unstructured":"Jacobi, A. M. et al. HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 69, 305\u2013308 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"59890_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.41992","volume":"74","author":"F Muratore","year":"2022","unstructured":"Muratore, F. et al. VEXAS syndrome: A case series from a single-center cohort of italian patients with vasculitis. Arthritis Rheumatol. 74, 665\u2013670 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"59890_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.41957","volume":"74","author":"A Sharma","year":"2022","unstructured":"Sharma, A., Naidu, G., Deo, P. & Beck, D. B. VEXAS syndrome with systemic lupus erythematosus: Expanding the spectrum of associated conditions. Arthritis Rheumatol. 74, 369\u2013371 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"59890_CR39","first-page":"764","volume":"42","author":"M Salles","year":"2024","unstructured":"Salles, M., Fusta, X., Lidia, C., Esquius, M. & Minguez, S. Systemic lupus erythematosus in the elderly finally diagnosed as VEXAS syndrome. Clin. Exp. Rheumatol. 42, 764\u2013765 (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"59890_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","volume":"15","author":"K Oleinika","year":"2019","unstructured":"Oleinika, K., Mauri, C. & Salama, A. D. Effector and regulatory B cells in immune-mediated kidney disease. Nat. Rev. Nephrol. 15, 11\u201326 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"59890_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","volume":"25","author":"M Yamashita","year":"2019","unstructured":"Yamashita, M. & Passegue, E. TNF-alpha coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell 25, 357\u2013372.e357 (2019).","journal-title":"Cell Stem Cell"},{"key":"59890_CR42","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamadermatol.2024.1657","volume":"160","author":"IJ Tan","year":"2024","unstructured":"Tan, I. J. et al. Skin manifestations of VEXAS syndrome and associated genotypes. JAMA Dermatol 160, 822\u2013829 (2024).","journal-title":"JAMA Dermatol"},{"key":"59890_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.immuni.2010.07.012","volume":"33","author":"EK Koltsova","year":"2010","unstructured":"Koltsova, E. K. & Ley, K. The mysterious ways of the chemokine CXCL5. Immunity 33, 7\u20139 (2010).","journal-title":"Immunity"},{"key":"59890_CR44","doi-asserted-by":"crossref","unstructured":"Ley K. et al. Neutrophils: New insights and open questions. Sci Immunol 3, eaat4579 (2018).","DOI":"10.1126\/sciimmunol.aat4579"},{"key":"59890_CR45","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/ard-2024-225640","volume":"83","author":"J Hadjadj","year":"2024","unstructured":"Hadjadj, J. et al. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX. Ann. Rheum. Dis. 83, 1358\u20131367 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"59890_CR46","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood.2022016642","volume":"140","author":"M Heiblig","year":"2022","unstructured":"Heiblig, M. et al. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: A retrospective multicenter study. Blood 140, 927\u2013931 (2022).","journal-title":"Blood"},{"key":"59890_CR47","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41375-022-01698-8","volume":"36","author":"A Mekinian","year":"2022","unstructured":"Mekinian, A. et al. A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune\/inflammatory disorders and VEXAS syndrome associated with MDS and CMML. Leukemia 36, 2739\u20132742 (2022).","journal-title":"Leukemia"},{"key":"59890_CR48","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.3324\/haematol.2024.285519","volume":"109","author":"R Trikha","year":"2024","unstructured":"Trikha, R. et al. De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine. Haematologica 109, 3431\u20133434 (2024).","journal-title":"Haematologica"},{"key":"59890_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.129","volume":"8","author":"AM Aalbers","year":"2024","unstructured":"Aalbers, A. M., van Daele, P. L. A., Dalm, V., Valk, P. J. M. & Raaijmakers, M. Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome. Hemasphere 8, e129 (2024).","journal-title":"Hemasphere"},{"key":"59890_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","volume":"107","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins, R. J. et al. VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome). Haematologica 107, 1011\u20131013 (2022).","journal-title":"Haematologica"},{"key":"59890_CR51","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/rheumatology\/keae123","volume":"63","author":"R Echerbault","year":"2024","unstructured":"Echerbault, R. et al. Comparing clinical features between males and females with VEXAS syndrome: Data from literature analysis of patient reports. Rheumatol. (Oxf.) 63, 2694\u20132700 (2024).","journal-title":"Rheumatol. (Oxf.)"},{"key":"59890_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36109-8","volume":"14","author":"M Bissa","year":"2023","unstructured":"Bissa, M. et al. HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC. Nat. Commun. 14, 575 (2023).","journal-title":"Nat. Commun."},{"key":"59890_CR53","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.4049\/jimmunol.1203034","volume":"190","author":"T Zhang","year":"2013","unstructured":"Zhang, T., Scott, J. M., Hwang, I. & Kim, S. Cutting edge: Antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency. J. Immunol. 190, 1402\u20131406 (2013).","journal-title":"J. Immunol."},{"key":"59890_CR54","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.celrep.2016.04.005","volume":"15","author":"LL Liu","year":"2016","unstructured":"Liu, L. L. et al. Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans. Cell Rep. 15, 1088\u20131099 (2016).","journal-title":"Cell Rep."},{"key":"59890_CR55","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/eji.202170126","volume":"51","author":"A Cossarizza","year":"2021","unstructured":"Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur. J. Immunol. 51, 2708\u20133145 (2021).","journal-title":"Eur. J. Immunol."},{"key":"59890_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/cyto.a.24507","volume":"101","author":"R Carsetti","year":"2022","unstructured":"Carsetti, R. et al. Comprehensive phenotyping of human peripheral blood B lymphocytes in healthy conditions. Cytom. A 101, 131\u2013139 (2022).","journal-title":"Cytom. A"},{"key":"59890_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"59890_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"59890_CR59","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308.e1236 (2018).","journal-title":"Cell"},{"key":"59890_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0335-7","volume":"8","author":"D Redmond","year":"2016","unstructured":"Redmond, D., Poran, A. & Elemento, O. Single-cell TCRseq: Paired recovery of entire T-cell alpha and beta chain transcripts in T-cell receptors from single-cell RNAseq. Genome Med 8, 80 (2016).","journal-title":"Genome Med"},{"key":"59890_CR61","unstructured":"Team RC, R. A Language and Enviroment for Statistical Computing. R Foundation for Statistical Computing, (2023)."},{"key":"59890_CR62","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"59890_CR63","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"59890_CR64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184\u2013197 (2015).","journal-title":"Cell"},{"key":"59890_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet 25, 25\u201329 (2000).","journal-title":"Nat. Genet"},{"key":"59890_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245\u2013253 (2022).","journal-title":"Nat. Biotechnol."},{"key":"59890_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: Cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).","journal-title":"BMC Genomics"},{"key":"59890_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07959-x","volume":"12","author":"MSB Raredon","year":"2022","unstructured":"Raredon, M. S. B. et al. Computation and visualization of cell-cell signaling topologies in single-cell systems data using Connectome. Sci. Rep. 12, 4187 (2022).","journal-title":"Sci. Rep."},{"key":"59890_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0613-1","volume":"16","author":"VI Nazarov","year":"2015","unstructured":"Nazarov, V. I. et al. tcR: An R package for T cell receptor repertoire advanced data analysis. BMC Bioinforma. 16, 175 (2015).","journal-title":"BMC Bioinforma."},{"key":"59890_CR70","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"59890_CR71","unstructured":"Gao S. shouguog\/NHLBIGoT: NHLBIGoT. Zenoda (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59890-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:06:18Z","timestamp":1747739178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59890-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59890"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59890-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4690"}}